Publication Name	World Journal of Gastroenterology
Manuscript ID	4729
Country	Australia

Received	2013-07-19 11:52
Peer-Review Started	2013-07-19 23:04
To Make the First Decision	2013-09-02 16:27
Return for Revision	2013-09-03 21:32
Revised
Second Decision	2013-10-21 17:35
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-10-22 07:41
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-11-28 12:10
Publish the Manuscript Online	2013-12-18 10:39

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Ophthalmologic complications of antiviral therapy in hepatitis C treatment
Manuscript Source	Invited Manuscript
All Author List	Roderick O'Day, Mark C Gillies and Golo Ahlenstiel
Funding Agency and Grant Number	Funding Agency Grant Number National Health and Medical Research Council Project Grant APP1006759 Robert W. Storr Bequest to the Sydney Medical Foundation of the University of Sydney to Ahlenstiel G
Corresponding Author	Dr. Golo Ahlenstiel, Department of Gastroenterology and Hepatology, Westmead Hospital, Hawkesbury Road, Westmead, NSW 2145, Australia. golo.ahlenstiel@sydney.edu.au
Key Words	Interferon; Hepatitis C; Ocular complications; Retinopathy
Core Tip	Interferon-associated retinopathy is usually a benign, transient phenomenon with no lasting impact on visual function. It occurs in approximately 30% of patients receiving antiviral therapy for chronic hepatitis C infection. The main risk factors for its development appear to be hypertension and diabetes. Unless a clear benefit to patients can be shown, a screening program for the development of interferon-associated retinopathy is not justified. No conclusive evidence exists for a causal link between it and the atypical adverse events of antiviral therapy, which tend to cause irreversible vision loss.
Publish Date	2013-12-18 10:39
Citation	O’Day R, Gillies MC, Ahlenstiel G. Ophthalmologic complications of antiviral therapy in hepatitis C treatment. World J Gastroenterol 2013; 19(45): 8227-8237
URL	http://www.wjgnet.com/1007-9327/full/v19/i45/8227.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i45.8227

Full Article (PDF)	WJG-19-8227.pdf
Manuscript File	4729-Review.docx
Answering Reviewers	4729-Answering reviewers.pdf
Biostatistics Review Certificate	Biostatistician_Review_Report_20130719053229.pdf
Copyright License Agreement	4729-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	Ethics_Committee_20130719053100.pdf
Peer-review Report	4729-Peer review(s).pdf
Scientific Editor Work List	4729-Scientific editor work list.doc